1Schinder M, Humphrey PP. Localization of the Somatostatin sst2 (a) receptor in human cerebral cortex. Hippocampus and cerebellum [J]. Neuroreport, 1998, 9: 521-525.
3Westlin JE, Tiensu JE, Anlstrom H, et al. A new diagnostic method: somatostatin receptor scintigraphy of neuroendocrine tumors [J]. Antibody, 1992, 5: 367-383.
4Sreedharan SP, Kodama KT, Peterson KE, et al. Distinct subsets of somatostatin receptors on cultured human lymphocytes [J]. J BiolChem, 1989, 264: 949-953.
5Reubi JC, Horisberger U, Essed CE, et al. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas [J]. Gastroenterology, 1988, 95: 760-763.
6Eijek CH, Krenning EP, Bootsma A, et al. Somatostatin receptor scintigraphy in primary breast cancer [J]. Lancet,1994, 343: 640-643.
7Denzler B, Reubi JC. Expression of somatostarin receptors in peritumoral veins of human tumors [J]. Cancer, 1999, 85:188-198.
8Froidevaux S, Hintermann E, Torok M, et al. Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment [J]. Cancer Res, 1999, 59 (15): 3652-3657.
9Eriksson B, Oberg K. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook [J].Ann Oncol, 1999, 10 (Supp1-2): S31-38.
10Brazeaup V, Burgus R, Ling N, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone [J]. Science, 1973, 179: 77-79.?A
